(Q34161036)

English

Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Tae-jin Youn

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hainan Piao

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jin-sook Kwon

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

So-young Choi

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hyung-sam Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dae-gyun Park

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dong-woon Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Young-gyu Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Myeong-chan Cho

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

713-718

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Natural history of left ventricular size and function after acute myocardial infarction. Assessment and prediction by echocardiographic endocardial surface mapping

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Signaling in myocardial hypertrophy: life after calcineurin?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Cardioprotection by cyclosporine A in experimental ischemia and reperfusion--evidence for a nitric oxide-dependent mechanism mediated by endothelin

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Reduction of infarct size in isolated rat heart by CsA and FK506: possible role of phosphatase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Left ventricular hypertrophy: effect on survival

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Left ventricular hypertrophy: an initial response to myocardial injury

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Calcineurin Expression, Activation, and Function in Cardiac Pressure-Overload Hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Functional left ventricular aneurysm formation after acute anterior transmural myocardial infarction. Incidence, natural history, and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Global cardiac remodeling after acute myocardial infarction: a study in the rat model

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Calcineurin inhibitors and cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Pressure Overload Induces Severe Hypertrophy in Mice Treated With Cyclosporine, an Inhibitor of Calcineurin

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

21 January 2018

Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900120-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1388-9842(02)00120-4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34161036&oldid=2047686208"